We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.47B
AUM Growth
-$289M
Cap. Flow
-$262M
Cap. Flow %
-10.6%
Top 10 Hldgs %
61.17%
Holding
110
New
16
Increased
30
Reduced
10
Closed
25

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$15.8M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$14.7M
3
INCY icon
Incyte
INCY
+$14.3M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$11.2M
5
TEX icon
Terex
TEX
+$6.1M

Top Sells

Rank Stock Value
1
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$78.4M
2
AMGN icon
Amgen
AMGN
+$17.4M
3
DG icon
Dollar General
DG
+$13.9M
4
MJN
Mead Johnson Nutrition Company
MJN
+$12.5M
5
BRFS
BRF SA
BRFS
+$10.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.19%
2 Healthcare 24.42%
3 Financials 1.12%
4 Industrials 0.54%
5 Technology 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
51
DELISTED
bluebird bio
BLUE
$9.64M 0.39%
19,300
+7,720
+67% +$2.47M
HON icon
52
CALL
Honeywell
HON
$76.7B
$9.29M 0.38%
+111,289
New +$9.3M
COF icon
53
CALL
Capital One
COF
$130B
$8.26M 0.33%
+100,000
New +$7.77M
TEX icon
54
Terex
TEX
$7.49B
$8.22M 0.33%
200,000
+150,000
+300% +$6.1M
UAL icon
55
CALL
United Airlines
UAL
$39.3B
$8.21M 0.33%
+200,000
New +$8.62M
AGIO icon
56
Agios Pharmaceuticals
AGIO
$2.09B
$8.02M 0.32%
175,000
+75,000
+75% +$3.06M
FCX icon
57
CALL
Freeport-McMoran
FCX
$85.4B
$7.3M 0.3%
200,000
– –
IMGN
58
CALL
DELISTED
Immunogen Inc
IMGN
$6.52M 0.26%
550,000
+200,000
+57% +$2.51M
HOUS
59
CALL
DELISTED
Anywhere Real Estate
HOUS
$5.66M 0.23%
+150,000
New +$5.82M
AVNR
60
CALL
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$5.64M 0.23%
1,000,000
-300,000
-23% -$1.38M
CERE
61
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$5.49M 0.22%
1,024,021
– –
AIG icon
62
American International
AIG
$42.8B
$5.46M 0.22%
+100,000
New +$5.29M
CMCSK
63
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$5.33M 0.22%
100,000
+25,000
+33% +$1.33M
ARMK icon
64
Aramark
ARMK
$15B
$5.18M 0.21%
+277,000
New +$5.4M
NEOG icon
65
Neogen
NEOG
$2B
$5.06M 0.2%
333,333
+200,000
+150% +$2.97M
NG icon
66
CALL
NovaGold Resources
NG
$2.56B
$5.05M 0.2%
1,200,000
– –
MRTX
67
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5M 0.2%
250,000
– –
MS icon
68
CALL
Morgan Stanley
MS
$324B
$4.85M 0.2%
150,000
– –
XOMA
69
DELISTED
Xoma
XOMA
$4.59M 0.19%
50,000
– –
RL icon
70
Ralph Lauren
RL
$22.1B
$4.02M 0.16%
25,000
-25,000
-50% -$3.85M
CSLT
71
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.8M 0.15%
250,000
+150,000
+150% +$2.44M
ONIT
72
Onity Group
ONIT
$343M
$3.71M 0.15%
+6,667
New +$3.63M
XOMA
73
CALL
DELISTED
Xoma
XOMA
$3.67M 0.15%
+40,000
New +$3.47M
IRWD icon
74
Ironwood Pharmaceuticals
IRWD
$596M
$3.33M 0.13%
258,954
– –
RDN icon
75
Radian Group
RDN
$5.28B
$2.96M 0.12%
+200,000
New +$2.91M
1 2
3
4 5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q2 2014 Portfolio in Review

As of Q2 2014, Artal Group held 110 positions worth $2.47B, down 10% from $2.76B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Artal Group withdrew a net $262M in Q2 2014, closing 25 positions and reducing 10 holdings. Its most notable exit was FURIEX PHARMACEUTICALS INC COM STK (DE), an estimated $78.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Artal Group opened a new position in Amazon worth $16.2M.

  • Artal Group's largest Q2 2014 buy was Amazon: 1,000,000 shares worth $16.2M.
  • Artal Group added most to AUXILIUM PHARAMCEUTICALS INC in Q2 2014, an estimated $14.7M increase.
  • Artal Group's biggest Q2 2014 reduction was Ralph Lauren, cutting an estimated $3.85M.
  • Artal Group fully exited FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014, selling an estimated $78.4M.
  • Artal Group's ten largest holdings make up 61% of its $2.47B portfolio in Q2 2014.
  • Artal Group opened 16 new positions and closed 25 in Q2 2014.
  • Artal Group's portfolio value fell 10% quarter-over-quarter to $2.47B.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.